+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumococcal Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), Age Group (Adult, Children, Geriatric), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Pneumococcal Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), Age Group (Adult, Children, Geriatric), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Pneumococcal Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), Age Group (Adult, Children, Geriatric), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968848
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pneumococcal vaccine market is experiencing substantial transformation, propelled by advances in vaccine technology, adaptation to shifting public health strategies, and evolving global supply dynamics. Stakeholders navigating this environment must align innovation, regulatory compliance, and efficient distribution to sustain growth and maximize public health outcomes.

Market Snapshot: Current Size and Growth Dynamics in the Pneumococcal Vaccine Market

The global pneumococcal vaccine market grew from USD 11.56 billion in 2024 to USD 12.49 billion in 2025. Backed by a CAGR of 7.96%, the market is anticipated to reach USD 18.31 billion by 2030. This trajectory reflects deep-seated shifts in vaccine R&D priorities, changing immunization mandates, and broadened healthcare access strategies. As science-driven stakeholders and industry leaders advance product innovation, focus has intensified around value-based delivery models, equitable vaccine supply, and regional adaptation to meet both pediatric and adult immunization needs effectively.

Pneumococcal Vaccine Market Scope & Segmentation

This report provides a granular analysis of the pneumococcal vaccine market, dissecting its structure across multiple strategic axes to guide actionable planning for industry decision-makers.

  • Vaccine Types: Includes leading and emerging conjugate vaccines (PCV13, PCV15, PCV20) and polysaccharide vaccine platforms, reflecting differences in serotype coverage and support for next-generation product strategies.
  • Age Groups: Covers product utilization patterns for adults, children, and geriatric populations, with distinct drivers impacting pediatric programs, booster schedules, and dose tailoring for immunocompromised or elderly individuals.
  • Distribution Channels: Examines offline and online access pathways, highlighting the growing influence of digital platforms alongside established provider-based distribution.
  • End Users: Addresses purchasing and delivery mechanisms across ambulatory care centers, clinics, hospitals, and immunization centers, exposing differences in procurement cycles and patient outreach influence.
  • Regional Scope: Analysis includes key sub-regions within the Americas, Europe, Middle East & Africa, and Asia-Pacific, such as the United States, Brazil, China, India, and major European and Middle Eastern countries, reflecting wide-ranging regulatory, funding, and logistical environments.
  • Industry Participants: Evaluation covers strategies and product advancements of major companies such as AstraZeneca, Biological E. Limited, Biovac, F. Hoffmann-La Roche, GlaxoSmithKline, Incepta Pharmaceuticals, Lonza, Merck, Panacea Biotec, Pfizer, Sanofi, Serum Institute of India, Vaxcyte, and Walvax Biotechnology.

Key Takeaways for Senior Decision-Makers

  • Strategic focus is shifting toward next-generation conjugate formulas and differentiated serotype coverage to maintain competitive positioning and address unmet needs.
  • Healthcare authorities and industry leaders are emphasizing expanded adult immunization, changing the landscape from traditional childhood-centric models to comprehensive, lifelong protection strategies.
  • Digital health integration is redefining vaccine logistics and patient engagement, requiring operational adjustments and investment in real-time inventory, tracking, and digital ordering capabilities.
  • Emerging alliances with biotechnology and contract manufacturing partners are accelerating product innovation timelines and expanding geographic reach to adapt to rising demand volatility.
  • Health economics assessments and real-world evidence are increasingly critical in demonstrating value, supporting reimbursement negotiations, and shaping national immunization policies.

Tariff Impact: How U.S. 2025 Measures Reshape Global Supply and Cost Structures

Recent U.S. tariff changes in 2025 have introduced significant complexity to the global pneumococcal vaccine supply chain, elevating costs for active ingredients and finished doses. These shifts prompt pharmaceutical suppliers to rethink sourcing, local production strategies, and contractual partnerships. Public and non-profit programs face renewed pressure to optimize budget allocation while navigating evolving regulatory dialogues and collaborative negotiations to mitigate immediate impacts on vaccine accessibility, especially in underserved regions.

Methodology & Data Sources Supporting Rigorous Market Insights

This research leverages a comprehensive methodology, incorporating peer-reviewed scientific literature, regulatory filings, and market analytics platforms. In-depth interviews with immunologists, procurement leaders, and supply chain experts supplement quantitative data drawn from manufacturer disclosures, clinical trial registries, and government procurement databases. Scenario modeling and expert validation ensure robust insight alignment with industry realities.

Pneumococcal Vaccine Market: Why This Report Matters

  • Enables rapid identification of market opportunities by revealing actionable segmentation insights and highlighting changes in procurement and demand drivers.
  • Supports executive decisions by clarifying the strategic impact of technological innovation, regulatory trends, and regional differences within immunization frameworks.
  • Equips stakeholders to navigate external challenges—including tariff fluctuations and supply chain disruptions—through recommendations, collaboration avenues, and data-driven scenario planning.

Conclusion

The pneumococcal vaccine market continues to evolve through technology adoption, regulatory developments, and shifting public health priorities. Stakeholders who prioritize data-driven strategies and collaborative partnerships will be best positioned to leverage future market growth and support global immunization objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid integration of novel 20-valent pneumococcal conjugate vaccine in national immunization programs
5.2. Expansion of public private partnerships to improve vaccine access in underserved regions
5.3. Growing investment in mRNA based pneumococcal vaccine platforms for faster development
5.4. Shifting epidemiology with emergence of non vaccine serotypes driving next generation formulations
5.5. Regulatory accelerated approval pathways facilitating faster market entry for novel pneumococcal vaccines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pneumococcal Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Conjugate Vaccine
8.2.1. Pcv13
8.2.2. Pcv15
8.2.3. Pcv20
8.3. Polysaccharide Vaccine
9. Pneumococcal Vaccine Market, by Age Group
9.1. Introduction
9.2. Adult
9.3. Children
9.4. Geriatric
10. Pneumococcal Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Pneumococcal Vaccine Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.4. Hospitals
11.5. Immunization Centers
12. Americas Pneumococcal Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pneumococcal Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pneumococcal Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AstraZeneca PLC
15.3.2. Biological E. Limited
15.3.3. Biovac
15.3.4. F. Hoffmann-La Roche AG
15.3.5. GlaxoSmithKline plc
15.3.6. Incepta Pharmaceuticals Ltd.
15.3.7. Lonza AG
15.3.8. Merck & Co., Inc.
15.3.9. Panacea Biotec Limited
15.3.10. Pfizer, Inc.
15.3.11. Sanofi SA
15.3.12. Serum Institute of India Pvt. Ltd.
15.3.13. Vaxcyte Inc.
15.3.14. Walvax Biotechnology Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PNEUMOCOCCAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PNEUMOCOCCAL VACCINE MARKET: RESEARCHAI
FIGURE 24. PNEUMOCOCCAL VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 25. PNEUMOCOCCAL VACCINE MARKET: RESEARCHCONTACTS
FIGURE 26. PNEUMOCOCCAL VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PNEUMOCOCCAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV13, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV13, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV15, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV15, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV20, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV20, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 71. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 74. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 75. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 84. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 136. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 146. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 164. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 165. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 166. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 167. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 176. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 216. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 234. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 235. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 236. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 237. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 246. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 276. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 284. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 285. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 286. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 304. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 305. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 306. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 308. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 309. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 314. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 315. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 316. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 317. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 334. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

  • AstraZeneca PLC
  • Biological E. Limited
  • Biovac
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Incepta Pharmaceuticals Ltd.
  • Lonza AG
  • Merck & Co., Inc.
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Vaxcyte Inc.
  • Walvax Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.31 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Pneumococcal 13-valent Conjugate Vaccine Market by Age Group (Adolescents 13-17 Years, Adults 18-49 Years, Children 2-12 Years), End User (Private Sector, Public Sector), Distribution Channel, Indication, Formulation - Global Forecast 2025-2030 - Product Image

Pneumococcal 13-valent Conjugate Vaccine Market by Age Group (Adolescents 13-17 Years, Adults 18-49 Years, Children 2-12 Years), End User (Private Sector, Public Sector), Distribution Channel, Indication, Formulation - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Pneumococcal Vaccines - Global Strategic Business Report - Product Image

Pneumococcal Vaccines - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Pneumococcal Vaccine Market Report 2025 - Product Image

Pneumococcal Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pneumococcal Vaccine Market Report and Forecast 2025-2034 - Product Image

Pneumococcal Vaccine Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Pneumococcal Vaccine Market

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.